tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Charles River Laboratories International Inc

CRL
Add to Watchlist
234.300USD
-0.500-0.21%
Close 07-29 16:00（ET）Quotes delayed by 15 min
11.29BMarket Cap
LossP/E TTM

Charles River Laboratories International Inc

234.300
-0.500-0.21%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

CRL Financials

See Charles River Laboratories International Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Charles River Laboratories International Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/2.73
Revenue / Forecast
--/974.72M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
4.02B
-0.85%
EPS(YoY)
-2.91
-1553.10%
Analyst Rating
BUY
2026/07/29
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-160.33%-0.30
-33.22%-5.62
-17.25%1.11
-39.01%1.06
-61.60%0.50
-215.69%-4.22
-21.58%1.34
-7.85%1.75
-35.15%1.31
-0.95%3.65
--1.70
--1.89
--2.02
--3.68
--5.88
----
----
----
----
----
Revenue
1.18%995.83M
-0.83%994.23M
-0.49%1.00B
0.59%1.03B
-2.71%984.17M
-1.08%1.00B
-1.64%1.01B
-3.19%1.03B
-1.73%1.01B
-7.85%1.01B
3.79%1.03B
8.92%1.06B
12.63%1.03B
21.52%1.10B
10.40%989.16M
6.40%973.13M
10.84%913.93M
14.42%905.05M
20.54%895.94M
33.99%914.61M
Net Profit
-158.28%-14.84M
-28.21%-276.56M
-20.76%54.42M
-41.85%52.33M
-62.17%25.47M
-215.30%-215.70M
-21.41%68.68M
-7.25%89.99M
-34.72%67.33M
-0.17%187.08M
-9.42%87.39M
-11.25%97.02M
10.87%103.13M
36.22%187.41M
-6.72%96.47M
23.60%109.32M
51.18%93.02M
-3.92%137.58M
0.50%103.43M
31.16%88.45M
Net Margin
-156.53%-1.49%
-30.34%-27.79%
-20.58%5.53%
-44.42%5.11%
-64.29%2.63%
-214.36%-21.32%
-18.80%6.96%
-2.09%9.19%
-27.09%7.36%
8.43%18.64%
--8.57%
--9.38%
--10.10%
--17.19%
--10.55%
----
----
----
----
----
Gross Margin
10.64%30.90%
11.48%30.96%
-2.70%32.32%
-5.71%30.83%
-11.78%27.93%
-16.41%27.77%
-0.26%33.21%
-4.99%32.69%
-4.93%31.65%
0.54%33.23%
--33.30%
--34.41%
--33.30%
--33.05%
--33.12%
----
----
----
----
----
Debt to assets ratio
4.22%34.56%
0.64%29.99%
0.04%29.12%
1.76%30.89%
1.51%33.16%
-7.95%29.80%
-12.02%29.11%
-12.04%30.35%
-8.57%32.66%
-9.23%32.37%
--33.09%
--34.51%
--35.72%
--35.66%
--39.81%
----
----
----
----
----
Income Statement
Revenue
1.18%995.83M
-0.83%994.23M
-0.49%1.00B
0.59%1.03B
-2.71%984.17M
-1.08%1.00B
-1.64%1.01B
-3.19%1.03B
-1.73%1.01B
-7.85%1.01B
3.79%1.03B
8.92%1.06B
12.63%1.03B
21.52%1.10B
10.40%989.16M
6.40%973.13M
10.84%913.93M
14.42%905.05M
20.54%895.94M
33.99%914.61M
Operating profit
53.76%151.48M
33.28%120.22M
2.05%151.08M
-21.98%132.33M
-31.10%98.51M
-39.99%90.20M
-11.72%148.05M
2.07%169.61M
-15.38%142.98M
-8.24%150.31M
11.08%167.70M
-11.33%166.17M
13.56%168.96M
-9.96%163.81M
-7.94%150.98M
21.64%187.41M
11.79%148.78M
31.29%181.93M
22.82%164.00M
88.14%154.07M
Net Profit
-158.28%-14.84M
-28.21%-276.56M
-20.76%54.42M
-41.85%52.33M
-62.17%25.47M
-215.30%-215.70M
-21.41%68.68M
-7.25%89.99M
-34.72%67.33M
-0.17%187.08M
-9.42%87.39M
-11.25%97.02M
10.87%103.13M
36.22%187.41M
-6.72%96.47M
23.60%109.32M
51.18%93.02M
-3.92%137.58M
0.50%103.43M
31.16%88.45M
Balance Sheet
Current assets
-1.17%1.49B
3.13%1.45B
2.50%1.53B
-1.96%1.47B
-9.70%1.51B
-12.78%1.40B
3.49%1.49B
-0.37%1.50B
15.18%1.67B
11.79%1.61B
2.05%1.44B
8.02%1.50B
8.65%1.45B
12.95%1.44B
2.63%1.42B
9.87%1.39B
-6.33%1.33B
6.07%1.27B
20.94%1.38B
2.69%1.27B
Total current liabilities
4.06%1.09B
12.70%1.12B
10.83%1.12B
14.03%1.08B
10.08%1.05B
-5.78%994.10M
1.85%1.01B
-5.96%947.52M
-2.71%954.81M
-3.34%1.06B
-2.01%993.82M
-3.87%1.01B
-1.25%981.39M
5.65%1.09B
3.09%1.01B
12.75%1.05B
23.71%993.84M
23.03%1.03B
25.00%983.75M
27.70%929.61M
Total assets
1.95%7.73B
-5.22%7.14B
-6.12%7.51B
-4.88%7.56B
-7.00%7.58B
-8.13%7.53B
5.22%8.00B
2.26%7.95B
5.89%8.15B
7.79%8.20B
3.04%7.61B
3.23%7.77B
8.83%7.70B
8.24%7.60B
4.59%7.38B
12.04%7.53B
21.80%7.08B
27.93%7.02B
35.39%7.06B
28.23%6.72B
Total liabilities
9.25%4.74B
-2.39%3.92B
-2.71%4.06B
-0.34%4.16B
-2.43%4.34B
-11.37%4.02B
-1.88%4.18B
-6.65%4.18B
-2.06%4.45B
-0.94%4.54B
-9.65%4.26B
-7.52%4.47B
3.14%4.54B
3.32%4.58B
2.55%4.71B
10.76%4.84B
22.59%4.40B
32.42%4.43B
39.72%4.59B
26.18%4.37B
Total equity
-7.82%2.99B
-8.46%3.21B
-9.85%3.45B
-9.90%3.40B
-12.48%3.24B
-4.12%3.51B
14.24%3.83B
14.34%3.77B
17.33%3.70B
21.02%3.66B
25.40%3.35B
22.54%3.30B
18.20%3.16B
16.65%3.02B
8.41%2.67B
14.40%2.69B
20.51%2.67B
20.91%2.59B
28.00%2.46B
32.21%2.35B
Cash Flow Statement
Net operating income
-76.08%41.08M
-7.43%147.52M
-15.08%213.83M
5.72%204.60M
32.19%171.70M
-27.87%159.36M
22.56%251.79M
30.66%193.53M
18.75%129.89M
-5.88%220.94M
54.73%205.45M
-0.90%148.12M
6.58%109.38M
2.40%234.76M
-24.01%132.78M
-19.89%149.47M
-39.71%102.63M
65.67%229.26M
-1.45%174.72M
14.96%186.59M
Net investment
-796.78%-407.85M
-21.95%-92.81M
-58.02%-33.70M
39.65%-37.34M
46.99%-45.48M
68.07%-76.10M
73.20%-21.32M
19.24%-61.87M
49.12%-85.79M
-637.08%-238.37M
13.70%-79.56M
83.42%-76.61M
-72.05%-168.62M
376.88%44.38M
74.04%-92.19M
51.57%-462.11M
28.98%-98.00M
110.53%9.31M
-401.41%-355.05M
-3233.31%-954.19M
Net financing
430.14%347.72M
31.65%-51.86M
26.46%-152.62M
20.62%-226.92M
-674.10%-105.33M
-161.41%-75.88M
-27.43%-207.54M
-300.00%-285.86M
-27.32%18.35M
149.63%123.57M
-215.67%-162.87M
-126.33%-71.46M
290.02%25.24M
-13.69%-248.96M
-128.84%-51.59M
-47.59%271.44M
-106.82%-13.28M
-269.70%-218.97M
166.59%178.90M
597.57%517.96M

FAQs

What is the total revenue of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its total revenue reached 4.02B, with a year-on-year change of 4.05B.

What are the current assets of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its current assets were 1.45B, with a year-on-year change of 3.13.

What are the total assets of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its total assets of Charles River Laboratories International Inc were 7.14B, with a year-on-year change of -5.22.

What are the total liabilities of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its total liabilities of Charles River Laboratories International Inc were 3.92B, with a year-on-year change of -2.39.

What is the total equity of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its total equity of Charles River Laboratories International Inc was 3.21B, with a year-on-year change of -8.46.

What is the net operating income of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its net operating income of Charles River Laboratories International Inc was 502.15M, with a year-on-year change of -8.84.

What is the net investment of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its net investment of Charles River Laboratories International Inc was -191.88M, with a year-on-year change of 21.71.

What is the net financing of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its net financing of Charles River Laboratories International Inc was -536.73M, with a year-on-year change of 2.58.

What is the Earnings Per Share (EPS) of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.91, with a year-on-year change of -1553.10.

What is the net income of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its net income was -144.34M, with a year-on-year change of -1501.75.

What is the net margin of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its net profit margin was -3.54, with a year-on-year change of -666.95.

What is the gross margin of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its gross margin was 30.52, with a year-on-year change of -2.63.

What is the debt-to-asset ratio of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its debt-to-asset ratio was 29.99, with a year-on-year change of 0.64.

What is the Return on Equity (ROE) of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its Return on Equity (ROE) was -4.36, with a year-on-year change of -1593.19.

What is the Return on Assets (ROA) of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its Return on Assets (ROA) was -1.94, with a year-on-year change of -702.73.

What is the operating profit of Charles River Laboratories International Inc?

According to Charles River Laboratories International Inc's FY2025 earnings report, its operating profit was 502.15M, with a year-on-year change of -8.84.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy